Literature DB >> 25000122

Osteopontin O-glycosylation contributes to its phosphorylation and cell-adhesion properties.

Yoshinobu Kariya1, Mayumi Kanno1, Kana Matsumoto-Morita2, Midori Konno1, Yoshiki Yamaguchi2, Yasuhiro Hashimoto1.   

Abstract

OPN (osteopontin) is a multiphosphorylated extracellular glycoprotein, which has important roles in bone remodelling, inflammation and cancer metastasis. OPN regulates cell spreading and adhesion primarily through its association with several integrins such as αvβ3, and its phosphorylation affects these processes. However, the mechanism by which OPN O-glycosylation affects these processes is not completely understood. In the present study, we demonstrated that OPN O-glycosylation self-regulates its biological activities and also affects its phosphorylation status. We prepared two recombinant OPNs, WT (wild-type)-OPN and mutant OPN (ΔO-OPN), which lacks five O-glycosylation sites at a threonine/proline-rich region. O-glycan defects in OPN increased its phosphorylation level, as observed by dephosphorylation assays. Moreover, compared with WT-OPN, ΔO-OPN exhibited enhanced cell spreading and adhesion activities and decreased associations with β1 integrins. This suggested that defects in O-glycans in OPN altered these activities, and that β1 integrins have a less important role in adhesion to ΔO-OPN. The cell-adhesion activity of dephosphorylated ΔO-OPN was higher than the cell-adhesion activities of ΔO-OPN and dephosphorylated WT-OPN. This suggested that some of the phosphorylation in ΔO-OPN caused by O-glycan defects and O-glycans of OPN suppressed the OPN cell-adhesion activity. Thus functional activities of OPN can be determined by the combined glycosylation and phosphorylation statuses and not by either status alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25000122     DOI: 10.1042/BJ20140060

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.

Authors:  Kirstine Lavrsen; Sally Dabelsteen; Sergey Y Vakhrushev; Asha M R Levann; Amalie Dahl Haue; August Dylander; Ulla Mandel; Lars Hansen; Morten Frödin; Eric P Bennett; Hans H Wandall
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

Review 2.  Analysis of Mammalian O-Glycopeptides-We Have Made a Good Start, but There is a Long Way to Go.

Authors:  Zsuzsanna Darula; Katalin F Medzihradszky
Journal:  Mol Cell Proteomics       Date:  2017-11-21       Impact factor: 5.911

3.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

4.  LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.

Authors:  Runping Fang; Feifei Xu; Hui Shi; Yue Wu; Can Cao; Hang Li; Kai Ye; Yingyi Zhang; Qian Liu; Shuqin Zhang; Weiying Zhang; Lihong Ye
Journal:  Oncogene       Date:  2019-12-13       Impact factor: 9.867

5.  Identification of transglutaminase reactive residues in human osteopontin and their role in polymerization.

Authors:  Brian Christensen; Elias D Zachariae; Carsten Scavenius; Morten Thybo; Morten M Callesen; Søren Kløverpris; Claus Oxvig; Jan J Enghild; Esben S Sørensen
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

6.  The metastasis-inducing protein AGR2 is O-glycosylated upon secretion from mammary epithelial cells.

Authors:  Christopher Clarke; Philip Rudland; Roger Barraclough
Journal:  Mol Cell Biochem       Date:  2015-07-14       Impact factor: 3.396

7.  Recombinant human osteopontin expressed in Nicotiana benthamiana stimulates osteogenesis related genes in human periodontal ligament cells.

Authors:  Kaewta Rattanapisit; Supaniga Abdulheem; Daneeya Chaikeawkaew; Anchanee Kubera; Hugh S Mason; Julian K-C Ma; Prasit Pavasant; Waranyoo Phoolcharoen
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

8.  Effect of Phosphorylation on a Human-like Osteopontin Peptide.

Authors:  Samuel Lenton; Marco Grimaldo; Felix Roosen-Runge; Frank Schreiber; Tommy Nylander; Roger Clegg; Carl Holt; Michael Härtlein; Victoria García Sakai; Tilo Seydel; Susana C Marujo Teixeira
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

Review 9.  C1GALT1 in health and disease.

Authors:  Xiaojie Sun; Mengru Zhan; Xun Sun; Wanqi Liu; Xiangwei Meng
Journal:  Oncol Lett       Date:  2021-06-06       Impact factor: 2.967

10.  Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica.

Authors:  Yoshinobu Kariya; Yukiko Kariya; Toshie Saito; Shuhei Nishiyama; Takashi Honda; Keiko Tanaka; Mari Yoshida; Kazuo Fujihara; Yasuhiro Hashimoto
Journal:  BBA Clin       Date:  2015-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.